In elderly individuals high levels of interleukin-1b (IL-1b) in the brain have been implicated in infectionrelated behavioral pathologies but this has not been directly tested. Therefore, the current study investigated if sickness behavior in aged animals elicited by peripheral injection of lipopolysaccharide (LPS) is mediated through central IL-1b. Adult and aged mice were injected intracerebroventricularly with either saline or IL-1ra (4 lg) immediately prior to intraperitoneal administration of saline or LPS (10 lg) and locomotor and social behaviors were assessed. As anticipated, LPS depressed locomotor activity and social behavior in both adult and aged mice but the behavioral deficits were markedly greater in the aged at 24 h. Pretreatment with IL-1ra did not affect LPS-induced sickness behavior in adults; however, in aged mice IL-1ra attenuated LPS-induced sickness behavior, restoring it to the level exhibited by young adults. Twenty-four hours post-injection hippocampal and hypothalamic tissues were collected to determine IL-1b mRNA expression. Neither LPS nor IL-1ra affected IL-1b mRNA levels in adults, presumably because any effect of LPS had dissipated by 24 h. In contrast, IL-1b mRNA was markedly higher in aged mice 24 h after LPS, and prior treatment with IL-1ra either blocked or attenuated this effect in the hippocampus and hypothalamus, respectively. Taken together these data provide the first direct evidence that central IL-1b is responsible for the severe sickness behavior observed in aged animals after LPS treatment. Thus, inhibiting the central actions of IL-1b may be useful for minimizing behavioral complications in older individuals with an infection.
Introduction
Acute cognitive disorders such as delirium have been recognized as a frequent manifestation of peripheral infections in the elderly (Jackson et al., 2004; Wofford et al., 1996) . Indeed demented elderly patients are routinely screened for bladder infections because of the close association between infection and behavioral disorders, and a striking characteristic of pneumonia in the elderly is that it commonly presents clinically as delirium (Janssens and Krause, 2004) . The correlation between peripheral infection and behavioral disorders in the elderly is important because behavioral impairment leads to poor self care behavior (e.g. anorexia, weight loss, and noncompliance) and may ultimately increase rates of hospitalization and mortality (Armstrong et al., 1999; Jackson et al., 2004; Johnston et al., 1987; Wofford et al., 1996) . Currently, the mechanisms underlying infection-related behavioral disorders in the elderly are unknown.
During a peripheral infection, the immune system conveys a message to the brain and microglial cells respond and produce proinflammatory cytokines that help coordinate a behavioral response that is normally adaptive (Hart, 1988) . However, excessive production of proinflammatory cytokines in the brain can produce severe behavioral deficits that are maladaptive (Dantzer et al., 2008) . Recent studies of possible causes of infection-related behavioral disorders in the elderly indicated that in aged rodents peripheral infection induced an exaggerated proinflammatory cytokine response in the brain and signs of behavioral pathology not seen in younger cohorts, including prolonged anorexia (Godbout et al., 2005) , depressive-like behavior (Godbout et al., 2008) , and cognitive dysfunction (Barrientos et al., 2002; Chen et al., 2008) . Although aging appears to prime microglial cells to produce excessive levels of proinflammatory cytokines in response to signals from the peripheral immune system (Dilger and Johnson, 2008; Godbout et al., 2005; Godbout and Johnson, 2006; Henry et al., 2008; Perry, 2004) , it is not known if the discordant central cytokine response underlies the aberrant behavioral response.
To begin understanding this issue, the present study examined the contribution of interleukin-1b (IL-1b) in the brain to infection-related behavioral deficits in aged mice. Specifically, we evaluated sickness behavior in young adult and aged mice treated
